Southwest Oncology Group Phase II Trial (S0341) of Erlotinib (OSI-774) in Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2
Year: 2008
Type: article
Study design: Clinical Trial
Source: Journal of Thoracic Oncology
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: Southwest Oncology Group, G1202672505, G1257575315, G1331445602, G1790576020, G1958973285, G2043432835, G2064543036, G2276667821, G2435896781, G2562936776, G268786457, G2745671310, COLUMBIA UNIVERSITY SOUTHWEST ONCOLOGY GROUP PROGRAM, Southwest Oncology Group U10 Member Site, Ozark Health Ventures, LLC dba Cancer Research for the Ozarks, GRAND RAPIDS CLINICAL ONCOLOGY PROGRAM, G3041257426, SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER, UCDCCC NCTN U10 Program, G3242537740, Southeast Cancer Control Consortium, Inc, G3334379738, G3337849518, G3350348941, G3521018462, City of Hope Southwest Oncology Group Clinical Trials, G36541222, G3710026009, G3737421695, G379387698, G3939550896, G398851121, G413878341, Southwest Oncology Group, G425646771, Southwest Oncology Group, Southwest Oncology Group, UCDCCC NCTN UG1 PROGRAM, G5125348268, UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM, Santa Rosa Memorial Hospital Regional CCOP, Southwest Oncology Group Treatment Grant, Southwest Oncology Group, Bay Area Tumor Institute CCOP, SOUTHWEST ONCOLOGY GROUP STUDIES, University of Colorado Southwest Oncology Group, SOUTHWEST ONCOLOGY GROUP STUDY, Community Clinical Oncology Program, G7520596819, G763325562, ST Louis-Cape Girardeau CCOP, SOUTHWEST ONCOLOGY GROUP (UTAH), G869916006, G8740717309, G960417071, Montana Cancer Consortium CCOP, Southwest Oncology Group/University of California, Davis
OpenAlex ID: W2041035291
